Early Patient Access to Medicines: Health Technology Assessment Bodies Need to Catch Up with New Marketing Authorization Methods

Lada Leyens*, Angela Brand

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)187-191
JournalPublic Health Genomics
Issue number3
Publication statusPublished - 2016


  • Early dialogue
  • Marketing authorization application
  • Health technology assessment
  • European Medicines Agency
  • Food and Drug Administration
  • Adaptive pathways
  • Innovative medicines

Cite this